Mette Stockner

7.8k total citations · 1 hit paper
11 papers, 5.4k citations indexed

About

Mette Stockner is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Mette Stockner has authored 11 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Physiology. Recurrent topics in Mette Stockner's work include Diabetes Treatment and Management (5 papers), Diabetes Management and Research (4 papers) and Metabolism, Diabetes, and Cancer (3 papers). Mette Stockner is often cited by papers focused on Diabetes Treatment and Management (5 papers), Diabetes Management and Research (4 papers) and Metabolism, Diabetes, and Cancer (3 papers). Mette Stockner collaborates with scholars based in Denmark, United States and United Kingdom. Mette Stockner's co-authors include Steven P. Marso, Johannes F.E. Mann, Michael A. Nauck, Bernard Zinman, Gilbert H. Daniels, Lasse Steen Ravn, William M. Steinberg, John B. Buse, Peter Lommer Kristensen and Steven E. Nissen and has published in prestigious journals such as New England Journal of Medicine, Addictive Behaviors and Pancreas.

In The Last Decade

Mette Stockner

11 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

2016 4.9k citations Steven P. Marso, Gilbert H. Daniels et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mette Stockner Denmark	6	4.3k	1.9k	1.5k	948	907	11	5.4k
Lasse Steen Ravn Denmark	14	4.4k 1.0×	2.0k 1.1×	1.6k 1.0×	1.4k 1.5×	935 1.0×	24	5.7k
M. Angelyn Bethel United States	22	4.3k 1.0×	1.7k 0.9×	1.5k 1.0×	1.0k 1.1×	753 0.8×	39	5.1k
Richard M. Bergenstal United States	15	6.6k 1.5×	2.6k 1.4×	2.2k 1.4×	1.5k 1.5×	1.2k 1.3×	29	7.6k
Samuel S. Engel United States	37	3.7k 0.9×	1.4k 0.7×	1.2k 0.8×	743 0.8×	551 0.6×	127	5.1k
Kirstine Brown‐Frandsen Denmark	7	5.6k 1.3×	2.2k 1.2×	1.9k 1.3×	1.1k 1.1×	1.1k 1.2×	7	6.5k
Andrew Lewin United States	23	3.3k 0.8×	1.3k 0.7×	1.3k 0.9×	738 0.8×	914 1.0×	57	4.3k
Jennifer B. Green United States	31	3.6k 0.9×	1.4k 0.8×	1.3k 0.9×	1.5k 1.6×	442 0.5×	91	5.0k
Shamik Parikh United States	33	4.6k 1.1×	2.6k 1.4×	2.2k 1.5×	311 0.3×	987 1.1×	60	5.9k
Klaus A. Dugi Germany	39	2.9k 0.7×	1.4k 0.8×	1.6k 1.0×	741 0.8×	370 0.4×	72	4.4k
Carlos Abraira United States	28	5.1k 1.2×	1.3k 0.7×	1.2k 0.8×	1.3k 1.3×	419 0.5×	74	6.7k

Countries citing papers authored by Mette Stockner

Since Specialization

Citations

This map shows the geographic impact of Mette Stockner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mette Stockner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mette Stockner more than expected).

Fields of papers citing papers by Mette Stockner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mette Stockner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mette Stockner. The network helps show where Mette Stockner may publish in the future.

Co-authorship network of co-authors of Mette Stockner

This figure shows the co-authorship network connecting the top 25 collaborators of Mette Stockner. A scholar is included among the top collaborators of Mette Stockner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mette Stockner. Mette Stockner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Nauck, Michael A., Peter Lommer Kristensen, Lasse Steen Ravn, et al.. (2020). Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. UNC Libraries. 4 indexed citations

2.

Steinberg, William M., Michael A. Nauck, Alan C. Moses, et al.. (2020). LEADER 3—Lipase and Amylase Activity in Subjects With Type 2 Diabetes: Baseline Data From Over 9000 Subjects in the LEADER Trial. UNC Libraries. 4 indexed citations

3.

Raff, Evan, Irene Hramiak, Johannes F.E. Mann, et al.. (2017). Liraglutide and Renal Outcomes in Type 2 Diabetes: Results of the LEADER Trial. Canadian Journal of Diabetes. 41(5). S5–S5. 3 indexed citations

4.

Jacob, Stephan, J Lüdemann, Kirstine Brown‐Frandsen, et al.. (2017). Liraglutid und renale Endpunkte bei Typ 2 Diabetes: Ergebnisse der LEADER Studie. Diabetologie und Stoffwechsel. 12(S 01). S1–S84. 3 indexed citations

5.

Marso, Steven P., Gilbert H. Daniels, Kirstine Brown‐Frandsen, et al.. (2016). Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. New England Journal of Medicine. 375(4). 311–322. 4935 indexed citations breakdown →

6.

Steinberg, William M., Michael A. Nauck, Bernard Zinman, et al.. (2014). LEADER 3—Lipase and Amylase Activity in Subjects With Type 2 Diabetes. Pancreas. 43(8). 1223–1231. 56 indexed citations

7.

Walle, Johan Vande, Mette Stockner, Ann Raes, & Jens Peter Nørgaard. (2007). Desmopressin 30 Years in Clinical Use: A Safety Review. Current Drug Safety. 2(3). 232–238. 117 indexed citations

8.

Robèrt, Karl‐Henrik, Jan Samuelsson, C. Lindemalm, et al.. (1990). Treatment of myelodysplastic syndromes with retinoic acid and 1α‐hydroxy‐vitamin D3 in combination with low‐dose ara‐C is not superior to ara‐C alone. Results from a randomized study. European Journal Of Haematology. 45(5). 255–261. 35 indexed citations

9.

Tønnesen, Philip, et al.. (1988). Effect of Nicotine Chewing Gum in Combination with Group Counseling on the Cessation of Smoking. New England Journal of Medicine. 318(1). 15–18. 177 indexed citations

10.

Tønnesen, Philip, et al.. (1988). Two and four mg nicotine chewing gum and group counselling in smoking cessation: An open, randomized, controlled trial with a 22 month follow-up. Addictive Behaviors. 13(1). 17–27. 86 indexed citations

11.

Hansen, Michael D., et al.. (1988). Effect of Nicotine Chewing Gum in Combination with Group Counseling On the Cessation of Smoking. Journal of Cardiopulmonary Rehabilitation. 8(4). 159–159. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact